CLVS
CLVS Articles
Companies receiving analyst upgrades, downgrades, initiations or other key notes on Tuesday morning include Alcoa, Arch Coal, Baidu, Ciena, JD.com and Vale.
Published:
Last Updated:
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares hit a new 52-week high after the company reported a key U.S. Food and Drug Administration (FDA) approval. Essentially, the FDA approved...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Netflix, Nike, Pandora Media, SunPower and United Continental.
Published:
Last Updated:
Clovis Oncology shares saw a massive gain on Tuesday, on the heels of news that the FDA had granted it a priority review of its cancer drug.
Published:
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Clovis Oncology, Garmin, Lowe's, NetApp, On Deck, Pioneer Natural and RSP Permian.
Published:
Last Updated:
Clovis Oncology, Inc. (NASDAQ: CLVS) is watching its shares climb late Tuesday after the company announced a key U.S. Food and Drug Administration (FDA) approval. Note that this is the first of a few...
Published:
Last Updated:
Shares of Clovis Oncology dropped after the FDA Oncologic Drugs Advisory Committee voted against its lung cancer drug.
Published:
Last Updated:
Although the markets have made their comeback, some stocks are still slowing that recovery and punishing their shareholders. These companies hurt their shareholders last week.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Clovis Oncology, CSC, Norfolk Southern, Sprint, Square and Western Digital.
Published:
Last Updated:
April 12, 2016: Here are four stocks trading with relatively heavy volume among 17 equities making new 52-week lows in Tuesday’s session. The day’s NYSE winners led losers by about 3 to 1. Nasdaq...
Published:
Last Updated:
April 11, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Monday’s session. The day’s NYSE winners led losers by about 3-to-2. Nasdaq...
Published:
Last Updated:
Thursday's top analyst calls include General Electric, 3M, Shopify, SunPower, Zafgen, CIT, Ericsson, Honeywell.
Published:
Last Updated:
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny. These four companies with promising candidates all have dates with the agency this year.
Published:
Last Updated:
Pharmaceutical companies generally are involved in the lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk to a great amount of risk...
Published:
Last Updated:
24/7 Wall St. examines Valeant Pharmaceuticals and other biotech stocks with incredible gains or losses over the course of the past week.
Published:
Last Updated: